New European Drugs Policy Provides Platform For Comprehensive Continental Cannabis Reform
A NEW approach to drugs across the 27 member states of the European Union looks set to provide a platform
Peter
December 16, 2022
A NEW approach to drugs across the 27 member states of the European Union looks set to provide a platform
THE German cannabis industry, patients groups and doctors have launched a fightback against proposals which would have a detrimental impact
FURTHER delays to the Dutch adult-use cannabis trial look likely after the selected growers told the Government the proposed timeline
SIGNIFICANT developments from Germany this week helped add to the momentum of interest in cannabis stocks initially driven by President
LEADING North American cannabis retailer High Tide has unveiled plans to establish a High Street footprint in the emerging adult-use
BACK in 2019 at a US industry conference while discussing cannabis business models a top executive from JP Morgan said
FOLLOWING last week’s rally there has seen something of a lull with little movement for European cannabis stocks. Last week’s
UKRAINE is poised permit the use of medical cannabis opening up the potential treatment to over two million people. The
TRUSTT has secured €400,000 in pre-seed funding to finance its ambitious blockchain tracing platform, which it believes will allow it
TETRA Pharm has successfully completed its first external funding round raising €2m in capital to help it launch clinical trials
CHILL Brands Group saw its stock prices jump as much as 25% after announcing the appointment of Michael Sandore as
FUELLED by last year’s significant progress the European cannabis industry is looking forward to further positive developments in 2022. While
Stenocare CEO Thomas Skovlund Schnegelsberg reflects on 2021 and looks ahead to the challenges and opportunities that lie ahead in 2022
THIS has been a remarkable year for European cannabis with some significant milestones passed on an increasingly fruitful trek into
In a Q&A with BusinessCann Eoin Keenan, CEO & Co-Founder, Goodrays, says after seven years working in the industry he
GERMAN firm SynBiotic has just completed what it calls the ‘most significant merger in the European cannabis sector’ to date,
IT’S still early days but after a faltering start by its North American neighbours US cannabis companies are now taking
NEW analysis from Prohibition Partners on the trajectory of the cannabis industry predicts significant global growth over the coming years
We won’t spam you